Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.
Lundin J, Mulder TA, Kättström M, Wästerlid T, Uddevik A, Mellstedt H, Heimersson K, Hansson L, Palma M, Österborg A. Lundin J, et al. Among authors: heimersson k. EJHaem. 2021 Jul 14;2(3):525-529. doi: 10.1002/jha2.261. eCollection 2021 Aug. EJHaem. 2021. PMID: 35844699 Free PMC article.
Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.
Winqvist M, Palma M, Heimersson K, Mellstedt H, Österborg A, Lundin J. Winqvist M, et al. Among authors: heimersson k. Br J Haematol. 2018 Aug;182(4):590-594. doi: 10.1111/bjh.14836. Epub 2017 Jul 5. Br J Haematol. 2018. PMID: 28677818 Free article. Clinical Trial. No abstract available.
Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment.
Mulder TA, Andersson ML, Peña-Pérez L, Heimersson K, Xagoraris I, Wahlin BE, Månsson R, Hansson L, Rassidakis G, Palma M. Mulder TA, et al. Among authors: heimersson k. Hemasphere. 2022 Oct 26;6(11):e794. doi: 10.1097/HS9.0000000000000794. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36325271 Free PMC article.